annual CFO:
-$134.68M-$64.44M(-91.75%)Summary
- As of today (June 30, 2025), OCUL annual cash flow from operations is -$134.68 million, with the most recent change of -$64.44 million (-91.75%) on December 31, 2024.
- During the last 3 years, OCUL annual CFO has fallen by -$69.13 million (-105.46%).
- OCUL annual CFO is now -970.14% below its all-time high of -$12.59 million, reached on December 31, 2012.
Performance
OCUL Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$44.67M-$5.24M(-13.29%)Summary
- As of today (June 30, 2025), OCUL quarterly cash flow from operations is -$44.67 million, with the most recent change of -$5.24 million (-13.29%) on March 31, 2025.
- Over the past year, OCUL quarterly CFO has dropped by -$10.78 million (-31.82%).
- OCUL quarterly CFO is now -1467.40% below its all-time high of -$2.85 million, reached on September 30, 2013.
Performance
OCUL quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$145.46M-$10.78M(-8.01%)Summary
- As of today (June 30, 2025), OCUL TTM cash flow from operations is -$145.46 million, with the most recent change of -$10.78 million (-8.01%) on March 31, 2025.
- Over the past year, OCUL TTM CFO has dropped by -$61.31 million (-72.86%).
- OCUL TTM CFO is now -4207.40% below its all-time high of -$3.38 million, reached on March 31, 2013.
Performance
OCUL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OCUL Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.8% | -31.8% | -72.9% |
| 3 y3 years | -105.5% | -140.2% | -117.8% |
| 5 y5 years | -73.6% | -136.9% | -88.8% |
OCUL Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -126.0% | at low | -477.7% | at low | -152.5% | at low |
| 5 y | 5-year | -151.5% | at low | -615.2% | at low | -179.4% | at low |
| alltime | all time | -970.1% | at low | -1467.4% | at low | -4207.4% | at low |
OCUL Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$44.67M(+13.3%) | -$145.46M(+8.0%) |
| Dec 2024 | -$134.68M(+91.8%) | -$39.43M(+7.9%) | -$134.68M(+14.4%) |
| Sep 2024 | - | -$36.56M(+47.4%) | -$117.70M(+32.4%) |
| Jun 2024 | - | -$24.80M(-26.8%) | -$88.88M(+5.6%) |
| Mar 2024 | - | -$33.89M(+50.9%) | -$84.15M(+19.8%) |
| Dec 2023 | -$70.23M(+17.8%) | -$22.45M(+190.4%) | -$70.23M(+8.5%) |
| Sep 2023 | - | -$7.73M(-61.5%) | -$64.74M(-7.7%) |
| Jun 2023 | - | -$20.07M(+0.5%) | -$70.17M(+15.1%) |
| Mar 2023 | - | -$19.97M(+17.8%) | -$60.98M(+2.3%) |
| Dec 2022 | -$59.60M(-9.1%) | -$16.96M(+28.8%) | -$59.60M(+3.1%) |
| Sep 2022 | - | -$13.17M(+21.1%) | -$57.80M(+0.3%) |
| Jun 2022 | - | -$10.88M(-41.5%) | -$57.61M(-13.7%) |
| Mar 2022 | - | -$18.60M(+22.7%) | -$66.79M(+1.9%) |
| Dec 2021 | -$65.55M(+22.4%) | -$15.15M(+16.7%) | -$65.55M(+15.7%) |
| Sep 2021 | - | -$12.98M(-35.3%) | -$56.64M(-1.2%) |
| Jun 2021 | - | -$20.06M(+15.5%) | -$57.32M(+10.1%) |
| Mar 2021 | - | -$17.36M(+177.9%) | -$52.06M(-2.8%) |
| Dec 2020 | -$53.55M(-31.0%) | -$6.25M(-54.3%) | -$53.55M(-19.8%) |
| Sep 2020 | - | -$13.66M(-7.7%) | -$66.78M(-8.1%) |
| Jun 2020 | - | -$14.80M(-21.5%) | -$72.66M(-5.7%) |
| Mar 2020 | - | -$18.85M(-3.1%) | -$77.05M(-0.7%) |
| Dec 2019 | -$77.58M(+57.6%) | -$19.47M(-0.4%) | -$77.58M(+8.1%) |
| Sep 2019 | - | -$19.54M(+1.9%) | -$71.76M(+13.7%) |
| Jun 2019 | - | -$19.18M(-1.1%) | -$63.09M(+12.4%) |
| Mar 2019 | - | -$19.39M(+42.0%) | -$56.14M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$49.23M(-2.5%) | -$13.65M(+25.5%) | -$49.23M(+7.1%) |
| Sep 2018 | - | -$10.87M(-11.1%) | -$45.96M(-7.1%) |
| Jun 2018 | - | -$12.23M(-1.9%) | -$49.47M(+2.3%) |
| Mar 2018 | - | -$12.47M(+20.1%) | -$48.37M(-4.2%) |
| Dec 2017 | -$50.47M(+48.4%) | -$10.38M(-27.8%) | -$50.47M(+5.8%) |
| Sep 2017 | - | -$14.38M(+29.2%) | -$47.70M(+17.3%) |
| Jun 2017 | - | -$11.13M(-23.6%) | -$40.65M(+3.4%) |
| Mar 2017 | - | -$14.58M(+91.5%) | -$39.32M(+15.6%) |
| Dec 2016 | -$34.00M(+0.8%) | -$7.61M(+3.8%) | -$34.00M(-2.9%) |
| Sep 2016 | - | -$7.33M(-25.2%) | -$35.02M(-6.3%) |
| Jun 2016 | - | -$9.80M(+5.9%) | -$37.39M(+3.5%) |
| Mar 2016 | - | -$9.26M(+7.2%) | -$36.12M(+7.0%) |
| Dec 2015 | -$33.74M(+64.6%) | -$8.64M(-11.0%) | -$33.74M(+9.8%) |
| Sep 2015 | - | -$9.70M(+13.7%) | -$30.73M(+12.3%) |
| Jun 2015 | - | -$8.53M(+24.0%) | -$27.37M(+17.2%) |
| Mar 2015 | - | -$6.88M(+22.3%) | -$23.35M(+13.9%) |
| Dec 2014 | -$20.50M(+62.1%) | -$5.63M(-11.2%) | -$20.50M(+11.8%) |
| Sep 2014 | - | -$6.33M(+40.4%) | -$18.33M(+23.5%) |
| Jun 2014 | - | -$4.51M(+12.1%) | -$14.84M(+11.7%) |
| Mar 2014 | - | -$4.03M(+16.4%) | -$13.29M(+5.1%) |
| Dec 2013 | -$12.64M(+0.5%) | -$3.46M(+21.3%) | -$12.64M(+37.6%) |
| Sep 2013 | - | -$2.85M(-3.7%) | -$9.19M(+45.0%) |
| Jun 2013 | - | -$2.96M(-12.3%) | -$6.34M(+87.7%) |
| Mar 2013 | - | -$3.38M | -$3.38M |
| Dec 2012 | -$12.59M | - | - |
FAQ
- What is Ocular Therapeutix annual cash flow from operations?
- What is the all time high annual CFO for Ocular Therapeutix?
- What is Ocular Therapeutix annual CFO year-on-year change?
- What is Ocular Therapeutix quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly CFO year-on-year change?
- What is Ocular Therapeutix TTM cash flow from operations?
- What is the all time high TTM CFO for Ocular Therapeutix?
- What is Ocular Therapeutix TTM CFO year-on-year change?
What is Ocular Therapeutix annual cash flow from operations?
The current annual CFO of OCUL is -$134.68M
What is the all time high annual CFO for Ocular Therapeutix?
Ocular Therapeutix all-time high annual cash flow from operations is -$12.59M
What is Ocular Therapeutix annual CFO year-on-year change?
Over the past year, OCUL annual cash flow from operations has changed by -$64.44M (-91.75%)
What is Ocular Therapeutix quarterly cash flow from operations?
The current quarterly CFO of OCUL is -$44.67M
What is the all time high quarterly CFO for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly cash flow from operations is -$2.85M
What is Ocular Therapeutix quarterly CFO year-on-year change?
Over the past year, OCUL quarterly cash flow from operations has changed by -$10.78M (-31.82%)
What is Ocular Therapeutix TTM cash flow from operations?
The current TTM CFO of OCUL is -$145.46M
What is the all time high TTM CFO for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM cash flow from operations is -$3.38M
What is Ocular Therapeutix TTM CFO year-on-year change?
Over the past year, OCUL TTM cash flow from operations has changed by -$61.31M (-72.86%)